BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28267398)

  • 1. Metastatic Pancreatic Cancer.
    Hogendorf P; Durczyński A; Strzelczyk J
    J Invest Surg; 2018 Apr; 31(2):151-152. PubMed ID: 28267398
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer.
    Gruhl JD; Garrido-Laguna I; Francis SR; Affolter K; Tao R; Lloyd S
    Cancer Med; 2020 Mar; 9(5):1703-1711. PubMed ID: 31945808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.
    Fogel EL; Shahda S; Sandrasegaran K; DeWitt J; Easler JJ; Agarwal DM; Eagleson M; Zyromski NJ; House MG; Ellsworth S; El Hajj I; O'Neil BH; Nakeeb A; Sherman S
    Am J Gastroenterol; 2017 Apr; 112(4):537-554. PubMed ID: 28139655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
    Alemi F; Alseidi A; Scott Helton W; Rocha FG
    Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic cancer subtypes: a roadmap for precision medicine.
    Torres C; Grippo PJ
    Ann Med; 2018 Jun; 50(4):277-287. PubMed ID: 29537309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for subtypes of pancreatic ductal adenocarcinoma.
    Venkatesan P
    Lancet Oncol; 2017 Dec; 18(12):e718. PubMed ID: 29129444
    [No Abstract]   [Full Text] [Related]  

  • 8. Resection for recurrent pancreatic cancer in the remnant pancreas after pancreatectomy is clinically promising: Results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Yamada S; Kobayashi A; Nakamori S; Baba H; Yamamoto M; Yamaue H; Fujii T
    Surgery; 2018 Nov; 164(5):1049-1056. PubMed ID: 30068484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal tubulopapillary neoplasm (ITPN) of the pancreas associated with an invasive component: a case report with review of the literature.
    Kuscher S; Steinle H; Soleiman A; Öfner D; Schneeberger S; Oberhuber G
    World J Surg Oncol; 2017 Nov; 15(1):203. PubMed ID: 29145864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of pancreatic cancer.
    De La Cruz MS; Young AP; Ruffin MT
    Am Fam Physician; 2014 Apr; 89(8):626-32. PubMed ID: 24784121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors for long-term survival in patients with pancreatic ductal adenocarcinoma].
    Kawaida H; Fujii H
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():181-5. PubMed ID: 25857011
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreas Solid Tumors.
    Younan G
    Surg Clin North Am; 2020 Jun; 100(3):565-580. PubMed ID: 32402301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.
    Grossberg AJ; Chu LC; Deig CR; Fishman EK; Hwang WL; Maitra A; Marks DL; Mehta A; Nabavizadeh N; Simeone DM; Weekes CD; Thomas CR
    CA Cancer J Clin; 2020 Sep; 70(5):375-403. PubMed ID: 32683683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Intraglandular Metastases in a Patient with Invasive Ductal Carcinoma of the Pancreas.
    Morita S; Onaya H; Kishi Y; Hiraoka N; Arai Y
    Intern Med; 2015; 54(14):1753-6. PubMed ID: 26179530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of pancreatic cancer.
    Yeo CJ; Cameron JL
    Ann Chir Gynaecol; 2000; 89(3):225-33. PubMed ID: 11079793
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management.
    Aronsson L; Andersson R; Ansari D
    Scand J Gastroenterol; 2017 Aug; 52(8):803-815. PubMed ID: 28446039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic markers in pancreatic ductal adenocarcinomas.
    Hezel AF; Bardeesy N
    Cancer Biol Ther; 2008 Sep; 7(9):1360-1. PubMed ID: 18836287
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment strategy of intraductal papillary-mucinous tumor of the pancreas.
    Yamao K
    J Gastroenterol; 2005 Jul; 40(7):773-4. PubMed ID: 16082600
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mixed ductal endocrine carcinoma of the pancreas].
    Zehani A; Chelly I; Azouz H; Makni A; Haouet S; Kchir N
    Ann Pathol; 2012 Aug; 32(4):296-8. PubMed ID: 23010408
    [No Abstract]   [Full Text] [Related]  

  • 20. Irreversible electroporation: a novel therapy for stage III pancreatic cancer.
    Weiss MJ; Wolfgang CL
    Adv Surg; 2014; 48():253-8. PubMed ID: 25293620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.